• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 215/12 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms

Patent holdings for IPC class C07D 215/12

Total number of patents in this class: 475

10-year publication summary

29
25
26
25
41
24
32
21
19
8
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Merck Patent GmbH
5909
12
Bristol-myers Squibb Company
5080
11
Janssen Pharmaceutica N.V.
3839
11
Sun Pharma Advanced Research Company Ltd.
197
7
Ohio State Innovation Foundation
1770
6
Hendrix College
15
6
The Regents of the University of California
18943
5
Life Technologies Corporation
3068
5
The Scripps Research Institute
1364
5
VALO Health, Inc.
147
5
Shaanxi Lighte Optoelectronics Material Co., Ltd.
190
5
Novartis AG
11238
4
Samsung Display Co., Ltd.
30585
4
Boehringer Ingelheim International GmbH
4629
4
Massachusetts Institute of Technology
9795
4
Toray Industries, Inc.
6652
4
Katholieke Universiteit Leuven
1035
4
Agc, Inc.
4029
4
SpringWorks Therapeutics, Inc.
83
4
The Royal Institution for The Advancement of Learning / McGill University
622
4
Other owners 361